Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions demonstrate a high level of interest and moderate engagement, with posts emphasizing that all nine hospitalized SCD patients recovered, and referencing related health statistics, such as smoking rates, to contextualize the study. The tone suggests curiosity and cautious optimism about the potential implications of the research findings.
Most discussions support the positive findings of the study, indicating agreement on the notion that SCD patients experienced better COVID-19 outcomes than expected.
The prominence of the initial post and the sharing of new research results show high engagement and curiosity around this topic.
Responses involve sharing additional contextual information, such as specific patient outcomes and related health statistics, reflecting moderate depth in discussions.
While the responses highlight the significance of the findings, the overall influence appears preliminary, prompting further interest rather than immediate change.
Low morbidity and mortality with COVID-19 in sickle cell disease: A single center experience. #WSCD21 https://t.co/DbGaPs5kaM @graham74GC @BipinSavani https://t.co/iFV4oQmewC
New eJH research article: Low morbidity and mortality with COVID‐19 in sickle cell disease: A single center experience. https://t.co/sw7Wzh7SDR
978/ New York City, USA (adult smoking rate was 13.4% in 2017) Of 9 individuals with sickle cell disease ages 19 to 40 hospitalized with symptomatic Covid-19, one was a smoker (11.1%) All nine improved and were discharged home https://t.co/jH470ptoWm
RT @BritSocHaem: Low morbidity and mortality with COVID-19 in sickle cell disease: A single center experience. #WSCD21 https://t.co/DbGaPs5…
RT @BritSocHaem: Low morbidity and mortality with COVID-19 in sickle cell disease: A single center experience. #WSCD21 https://t.co/DbGaPs5…
RT @BritSocHaem: New eJH research article: Low morbidity and mortality with COVID‐19 in sickle cell disease: A single center experience. ht…
This study reports on nine sickle cell disease patients hospitalized with COVID-19 in New York City during early 2020, all of whom recovered and were discharged home, suggesting a potentially lower risk of severe…
This study reports on nine sickle cell disease patients hospitalized with COVID-19 in New York City during early 2020, all of whom recovered and were discharged home, suggesting a potentially lower risk of severe…
RT @BritSocHaem: Low morbidity and mortality with COVID-19 in sickle cell disease: A single center experience. #WSCD21 https://t.co/DbGaPs5…
RT @BritSocHaem: Low morbidity and mortality with COVID-19 in sickle cell disease: A single center experience. #WSCD21 https://t.co/DbGaPs5…
RT @BritSocHaem: Low morbidity and mortality with COVID-19 in sickle cell disease: A single center experience. #WSCD21 https://t.co/DbGaPs5…
Low morbidity and mortality with COVID-19 in sickle cell disease: A single center experience. #WSCD21 https://t.co/DbGaPs5kaM @graham74GC @BipinSavani https://t.co/iFV4oQmewC
@BBCChrisMorris Interesting...went looking for a little info and i found this... https://t.co/mnkpq8twHt
@coraIinejonz ببین حبیبی. تو تئوری داره میگه. تو عملی خیلی تحقیقات کمی صورت گرفته و 2 تا مقاله ای که الان رفتم دیدم نوشته ریسک مرگ کرونا تو بیمارای آنمی سیکل سل 5 و 7 درصد، که خب خیلی هم فرق نداره با ریسک مرگ عادی کرونا. لذا نگران نباش. :> https://t.co/hOMNJpTA2E https://t.co/L5mBgzAJGM
RT @BritSocHaem: New eJH research article: Low morbidity and mortality with COVID‐19 in sickle cell disease: A single center experience. ht…
New eJH research article: Low morbidity and mortality with COVID‐19 in sickle cell disease: A single center experience. https://t.co/sw7Wzh7SDR
978/ New York City, USA (adult smoking rate was 13.4% in 2017) Of 9 individuals with sickle cell disease ages 19 to 40 hospitalized with symptomatic Covid-19, one was a smoker (11.1%) All nine improved and were discharged home https://t.co/jH470ptoWm